Answers are grounded in this paper and cite their sources.
Injection of novel hydrogels enhances embolization effectiveness in hepatocellular carcinoma, suggesting improved treatment outcomes.
Although transarterial chemoembolization is a prevalent treatment for hepatocellular carcinoma (HCC), its efficacy is limited by inadequate vascular infiltration, inconsistent embolization, and lack of therapeutic synergy.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: